Published in Vaccine Weekly, September 12th, 2001
"Over 90% of cervical carcinomas express human papillomavirus (HPV) E6 and E7 proteins, noted M.R. Castellanos and colleagues. "These unique antigens are ideal targets for the development of cytotoxic T-lymphocytes (CTL) for anti-tumor immunotherapy."
Castellanos and team created a computer-assisted algorithm to predict which peptides from HPV-18 E6 and E7 proteins might bind to HLA-A2 molecules,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.